COVID-19 pandemisinde perioperatif planlama: Kardiyovasküler perfüzyon ve cihaza bağlı sorunlar

Kaynakça (7)

1. Mavioğlu HL, Ünal EU, Aşkın G, Küçüker ŞA, Özatik MA. Perioperative planning for cardiovascular operations in the COVID-19 pandemic. Turk Gogus Kalp Dama 2020;28:236-43
2. Tang YW, Schmitz JE, Persing DH, Stratton CW. The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges. J Clin Microbiol 2020. pii: JCM.00512-20. [Epub ahead of print] 3. Gunaydin S, McCusker K, Vijay V. Strategic leukofiltration in cardiac surgery. Curr Med Chem Cardiovasc Hematol Agents 2005;3:323-31
3. Gunaydin S. Clinical significance of coated extracorporeal circuits: a review of novel technologies. Perfusion 2004;19 Suppl 1:S33-41
4. Gunaydin S. Emerging technologies in biocompatible surface modifying additives: quest for physiologic cardiopulmonary bypass. Curr Med Chem Cardiovasc Hematol Agents 2004;2:295-302
5. Gunaydin S, McCusker K. The evolution of patient blood management programs in cardiac surgery: what is the ultimate frontier? Presented at the 57th AmSECT International Conference; 2019 Mar 8-10; Nashville, TN, USA
6. Gunaydin S, Gourlay T. Novel ultrafiltration technique for blood conservation in cardiac operations. Ann Thorac Surg 2013;95:2148-51
7. Angus DC. Optimizing the Trade-off Between Learning and Doing in a Pandemic. JAMA 2020. [Epub ahead of print] 9. Demirkılıç U, Gunaydin S, Doğancı S, Ural Z, editors. Extracorporeal Membrane Oxygenation (ECMO.) Ankara: Turkish Clinics Publishing; 2014.